Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer

Abstract

Together, our findings suggest that Tenascin C is a prognostic marker for patients with prostate cancer and that its effects might be mediated via regulation of the glycolysis process of prostate cancer cells.